Insiders · Profile

Yeramian Patrick D

Chief Medical Officer at Amylyx Pharmaceuticals. Filing since 6 Jan 2023. CIK 0001358266

Company
Date
Role
Action
Shares
Amount
Of holding
9 Jan 2024
Chief Medical Officer
Sold at will
2,812
$45.91K
1.3%
15 May 2023
Chief Medical Officer
Sold on a plan
11,965
$347.36K
5.4%
17 Apr 2023
Chief Medical Officer
Sold on a plan
49,579
$1.51M
19.2%
16 Mar 2023
Chief Medical Officer
Sold at will
54,627
$1.74M
26.7%
6 Jan 2023
Chief Medical Officer
Bought
2,034
$73.83K
1.0%
5 decisions on file.